Modular Antibody Technology
Our robust discovery engine lets us easily “mix-and-match” antibody components to create unique bispecific antibody products.
F-star develops genuine monoclonal bispecific antibodies that can bind two different targets at the same time, for use as “2-in-1” drugs.
News & Events
- 21 April 2016: F-star to Present at Conferences in April and May 2016
- 18 March 2016: F-star Moves into New Facility in Cambridge, UK and Expands its Management Team
- 23 February 2016: F-star to Present at Conferences in February and March 2016